Home / Uncategorized / New melanoma drug Zelboraf may double patients’ survival

New melanoma drug Zelboraf may double patients’ survival

Posted by: Philippe Matthews in Uncategorized Comments Off on New melanoma drug Zelboraf may double patients’ survival 394 Views

People with metastatic melanoma often live six to ten months; new drug prolonged life expectancy to 16 months

Continue reading here:
New melanoma drug Zelboraf may double patients’ survival

If you enjoyed this post, make sure you subscribe to my RSS feed!

Tagged with:

About Philippe Matthews

© 2014 the PM show – If You Like O, You Will Love P. All Rights Reserved. |A My Internet Marketing Expert Production
Scroll To Top